These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 18375356)

  • 1. The implications of colorectal cancer molecular biology in clinical practice.
    Kargozaran H; Kahlenberg M; Khatri VP
    Surg Oncol Clin N Am; 2008 Apr; 17(2):341-55, viii-ix. PubMed ID: 18375356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current concepts in the genetics of hereditary and sporadic colorectal cancer and the role of genetics in clinical practice: sporadic and IBD-associated colorectal tumors, significance of genetic tests in diagnosis, prognosis and assessment of chemotherapy outcome].
    Lakatos PL; Lakatos L
    Orv Hetil; 2006 Mar; 147(10):449-55. PubMed ID: 16573174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular biology of colorectal cancer: new targets.
    Kitisin K; Mishra L
    Semin Oncol; 2006 Dec; 33(6 Suppl 11):S14-23. PubMed ID: 17178280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular pathogenesis of colorectal cancer: implications for molecular diagnosis.
    Arnold CN; Goel A; Blum HE; Boland CR
    Cancer; 2005 Nov; 104(10):2035-47. PubMed ID: 16206296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: the chemoprevention of colorectal carcinoma.
    Gasche C
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():31-5. PubMed ID: 15352891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex differences in epidemiological, clinical and pathological characteristics of colorectal cancer.
    Koo JH; Leong RW
    J Gastroenterol Hepatol; 2010 Jan; 25(1):33-42. PubMed ID: 19874446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in colorectal cancer genetics and diagnostics.
    Cheah PY
    Crit Rev Oncol Hematol; 2009 Jan; 69(1):45-55. PubMed ID: 18774731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular biology of colorectal cancer development and the associated genetic events.
    Navaratnam RM; Chowaniec J; Winslet MC
    Ann R Coll Surg Engl; 1999 Sep; 81(5):312-9. PubMed ID: 10645173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers.
    Kodach LL; Wiercinska E; de Miranda NF; Bleuming SA; Musler AR; Peppelenbosch MP; Dekker E; van den Brink GR; van Noesel CJ; Morreau H; Hommes DW; Ten Dijke P; Offerhaus GJ; Hardwick JC
    Gastroenterology; 2008 May; 134(5):1332-41. PubMed ID: 18471510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular testing in colorectal cancer: diagnosis of Lynch syndrome and personalized cancer medicine.
    Shi C; Washington K
    Am J Clin Pathol; 2012 Jun; 137(6):847-59. PubMed ID: 22586043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common and distinct genomic events in sporadic colorectal cancer and diverse cancer types.
    Martin ES; Tonon G; Sinha R; Xiao Y; Feng B; Kimmelman AC; Protopopov A; Ivanova E; Brennan C; Montgomery K; Kucherlapati R; Bailey G; Redston M; Chin L; DePinho RA
    Cancer Res; 2007 Nov; 67(22):10736-43. PubMed ID: 18006816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxaliplatin-based chemotherapy in the management of colorectal cancer.
    Capdevila J; Elez E; Peralta S; Macarulla T; Ramos FJ; Tabernero J
    Expert Rev Anticancer Ther; 2008 Aug; 8(8):1223-36. PubMed ID: 18699761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular markers in prognosis of colorectal cancer and prediction of response to treatment.
    Pasche B; Mulcahy M; Benson AB
    Best Pract Res Clin Gastroenterol; 2002 Apr; 16(2):331-45. PubMed ID: 11969242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.
    Uddin S; Hussain AR; Ahmed M; Abubaker J; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Bavi P; Al-Kuraya KS
    Am J Gastroenterol; 2009 Jul; 104(7):1790-801. PubMed ID: 19491830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Familial colorectal cancer type X: clinical, pathological and molecular characterization].
    Ferreira S; Lage P; Sousa R; Claro I; Francisco I; Filipe B; Suspiro A; Chaves P; Rodrigues P; Albuquerque C; Nobre Leitão C
    Acta Med Port; 2009; 22(3):207-14. PubMed ID: 19686620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial colorectal cancer, can it be identified by microsatellite instability and chromosomal instability? - A case-control study.
    Sunde L; Bisgaard ML; Soll-Johanning H; Jacobsen NO; Bolund L; Skouv J; Lynge E
    Cancer Biomark; 2009; 5(4):197-205. PubMed ID: 19729829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of genetic variations in the VEGF system in relation to colorectal cancer.
    Hansen TF; Jakobsen A
    Pharmacogenomics; 2011 Dec; 12(12):1681-93. PubMed ID: 22118052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis and colorectal cancer: implications for therapy.
    Yang SY; Sales KM; Fuller B; Seifalian AM; Winslet MC
    Trends Mol Med; 2009 May; 15(5):225-33. PubMed ID: 19362056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomics and -genetics in colorectal cancer.
    Pohl A; Lurje G; Manegold PC; Lenz HJ
    Adv Drug Deliv Rev; 2009 May; 61(5):375-80. PubMed ID: 19100300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the biology of colorectal cancer.
    Grogan L; Behan KA; Johnston PG
    Histol Histopathol; 1996 Jul; 11(3):807-20. PubMed ID: 8839768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.